Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...
In this exclusive video interview, study author J. Bryan Sexton, PhD, of the Duke Center for the Advancement of Well-Being ...
The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...
Deaths related to extreme temperatures in the U.S. were projected to increase substantially by the mid-21st century, with ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...
Among its incorrect claims, the Florida bulletin says the new mRNA boosters wrongly target a viral variant, Omicron, that is ...
Recovery chairs, surgical equipment, and lighting from the Missouri clinic -- all expensive and perfectly good -- could still ...
"Do a real study, then we can talk about the data." -- Theo Heller, MD, of the National Institute of Diabetes and Digestive ...
And the agency expanded the approval of bimekizumab (Bimzelx) to include psoriatic arthritis, non-radiographic axial spondyloarthritis, and ankylosing spondylitis, UCB Announced.
More than 3 years ago, a small group of government scientists came forward with disturbing allegations.
Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...
This week, we learned about the tragic and preventable deaths of two women in Georgia from ProPublica. In the case of Amber ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback